Trade Nektar Therapeutics - NKTR CFD

Nektar Company profile

About Nektar Therapeutics

Nektar Therapeutics is a research-based biopharmaceutical company, which is focused on discovering and developing medicines in areas of unmet medical need. The Company's research and development pipeline of new investigational drugs includes potential therapies for oncology, immunology and virology. In oncology, it is studying several immuno-oncology (I-O) drug candidates, including bempegaldesleukin, NKTR-255 and NKTR-262. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In autoimmune disorders, its IL-2 T-regulatory cell stimulator NKTR-358 is being clinically studied in systemic lupus erythematosus, ulcerative colitis, psoriasis and atopic dermatitis. Its programs in virology area include studying bempegaldesleukin in treating individuals affected with COVID-19, and a preclinical research collaboration with Gilead Sciences Inc. (Gilead) to test the combination of NKTR-255.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Nektar Therapeutics revenues decreased 33% to $101.9M. Net loss increased 18% to $523.8M. Revenues reflect United States segment decrease of 84% to $10.1M. Higher net loss reflects Non-cash interest expense on liabilities increase of 56% to $47.3M (expense), Interest income and other income (expens decrease of 86% to $2.6M (income).

Equity composition

Common Stock $.0001 Par, 04/11, 300M auth., 114,073,353 issd.Insiders own 0.39% . IPO: 5/94,2.15M shares @ $7.50 by Lehman Brothers. PO 12/97, 1.725Mshares @ $24.875 by Lehman Brothers. *NOTE: 2/97, 1.8M shsissued in private placement @ $18/shs. 8/00, 2-for-1 stock split. Sr B Conv. Pfd. $0.0001 Par, 0 o/s.

Latest shares articles

US trade deals bring relief rally ahead of August 1 trade deadline
US trade deals support sentiment as August 1 trade deadline approaches
10:16, 28 July 2025
US trade deals bring relief rally ahead of August 1 trade deadline
US trade deals support sentiment as August 1 trade deadline approaches
10:16, 28 July 2025
Market Mondays: Tariff Deals, Tech Earnings and Fed Signals
This week will be very busy on the economic and earnings calendars with key events like the FOMC, BOJ, NFPs, and key tech earnings happening in the next few days.
10:03, 28 July 2025
Market Mondays: Tariff Deals, Tech Earnings and Fed Signals
This week will be very busy on the economic and earnings calendars with key events like the FOMC, BOJ, NFPs, and key tech earnings happening in the next few days.
10:03, 28 July 2025

Read our reviews to find out more about us

Read the feedback from our clients around the world.
2025-07-01
Victor Flemming Nandwa Søder

Great customer service I got to say that. They helped get my account back very fast, after i logged myself out by losing my old email, it was so fast you wouldn’t believe it thank you once again.

2025-07-01
Perry Reineke

I'm learning the basics of stock investing. This platform is clear and pretty good. I've been using it for over 6 months.

2025-06-30
Brigman

Everything worked as expected from the 1 day. I didn’t have to search how to use the platform, it’s intuitive. The support chat was there when I had a tiny issue.

2025-06-29
proinpro

Capital is really great to be used on start, also beginner friendly broker! Great costumer support and it is quick!

2025-06-27
Gio Gvazava

Capital.com has been great for both learning and trading. The app is clean, fast, and packed with useful tools. Customer support has been solid too. Definitely recommended for beginners and active traders alike.

2025-06-22
Jean A.

The app is built to make options and figures easy to understand, great for beginners and intermediate traders. Demo accounts are simple to set up. 100:1 leverage is available.

2025-06-22
Douglas

Deposits and withdrawals work without issues. Very low spreads. No noticeable fees. Easy to follow.

2025-06-19
dgogidze7

I would like to express a huge thank you to Evgeniya Logvinovich, customer service manager. For your attention and heartfelt attitude to your clients.❤️

2025-06-19
foobarbeer

I am extremely happy with this broker. Great spreads, good selection of instruments, well coded toolbox.

2025-05-29
Casaubon70

Love the TV integration. Makes traders life smooth and comfortable.

2025-05-24
Radioilluminati

I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!

2025-05-20
GemzT

I’d been paper trading for 2yrs now, went live and this platform is easy for beginners to understand and navigate all important tools to execute all that I learned. Earning now!

2025-05-06
Mahran Rahim Bakhsh Rasool Bakhsh Al Balushi

It's a great app, and it's safe to practice with the demo. Then, when you're ready for the real thing, I'd suggest installing it.

2025-04-29
dmjnoor

This application is perfect.. simple, easy to use, run smoothly and fast and it has an accurate graphics.. be careful to use only one credit card and one bank account to prevent any withdrawal problem.. overnight fees and spread variation will be repaid for you by the next month.. I used many application but this is the best one

2025-03-24
Debbie P

The best trading company I've found so far and so easy to use.

2025-02-06
Nouman Butt

User friendly app & interface and good support team. Funds transfer ease & Leverage is an advantage but crypto is highly risky be responsible of your loss limits and risks appetite.

2025-01-30
Claus-Bernhard Schuetze

Awesome trading platform On both desktop and mobile and u can start with low budget as the contracts can be adjusted and when u have confidence u can start full trading - being integrated in tradingview is absolutely awesome as well

Showing our 4 & 5 star reviews.

Ready to join a leading broker?

Join our community of traders worldwide
1. Create your account2. Make your first deposit3. Start trading